Striatech Debuts New Non-Aversive Animal Platform
Striatech, a leader in preclinical vision research devices and tools, has unveiled its New Non-Aversive Animal Platform for the OptoDrum
Read more
Neurology
Sanofi Bolsters Alzheimer’s Disease Pipeline with $470M Acquisition of Vigil Neuroscience
Sanofi has announced a definitive agreement to acquire clinical-stage biotech firm Vigil Neuroscience, Inc., in a move to expand its
Read more
Striatech Leads Ethical Vision Research at FELASA 2025
Striatech, a pioneer in non-invasive vision research technologies, will showcase its latest advancements at the FELASA 2025 Congress in Athens,
Read more
In Vivo Assessment of Visual Performance in Mice
The unique OptoDrum device for automated in vivo assessment of visual performance in mice and rats offers unmatched capabilities for
Read more
Striatech Backs ARVO’s Rising Vision Scientist
At Striatech, advancing the future of ophthalmic research is a central commitment. In partnership with the ARVO Foundation for Eye
Read more
Microglia Demyelination Shields CNS from Axonal Damage
A groundbreaking study by Groh et al., recently featured in Nature Communications, delves into the interplay between adaptive immunity and
Read more
Dark Adaptation in Rodents
DarkAdapt, an advanced extension of the OptoDrum system, enables precise and reproducible studies with dark-adapted rodents. This innovative instrument provides
Read more
Harvard Scientists Reverse Age-Related Vision Loss
Groundbreaking research from Harvard Medical School indicates that vision loss caused by optic nerve damage, glaucoma, and aging may not
Read more
The Unexpected Role of Subretinal Microglia in Aging Retina
The Ksander Lab at Boston’s Schepens Eye Research Institute has unveiled valuable insights into the role of subretinal microglia in
Read more
Breakthrough in Vision Restoration Through Optogenetics
Millions of individuals worldwide are affected by vision loss caused by retinal degenerative diseases, such as retinitis pigmentosa (RP) and
Read more